FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

2950911000001103: Supralip 160mg tablets (Viatris UK Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2123261000001117 Supralip 160mg tablets (Viatris UK Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2123271000001110 Supralip 160mg tablets (Viatris UK Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
17446101000001117 Supralip 160mg modified-release tablets (Fournier Pharmaceuticals Ltd) (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17446201000001112 Supralip 160mg modified-release tablets (Fournier Pharmaceuticals Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38122701000001113 Supralip 160mg tablets (Solvay Healthcare Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
41067701000001119 Supralip 160mg tablets (Fournier Pharmaceuticals Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
42825901000001119 Supralip 160mg tablets (Solvay Healthcare Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
63708401000001114 Supralip 160mg tablets (Abbott Healthcare Products Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
90070301000001111 Supralip 160mg tablets (BGP Products Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
102368701000001113 Supralip 160mg tablets (Mylan Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
105703301000001116 Supralip 160mg tablets (Mylan) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Supralip 160mg tablets (Viatris UK Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) Is a Product containing precisely fenofibrate micronized 160 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) Has active ingredient Fenofibrate micronized false Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) Is a Supralip true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) Has specific active ingredient Fenofibrate micronized true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Supralip 160mg tablets (Viatris UK Healthcare Ltd) 28 tablet 4 x 7 tablets Is pack of False Supralip 160mg tablets (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Viatris UK Healthcare Ltd) 28 tablet 4 x 7 tablets Has AMP True Supralip 160mg tablets (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start